Impilo Partners with Elation to Transform Healthcare Delivery
Impilo Enhances At-Home Healthcare with New Partnership
Impilo, a frontrunner in advancing at-home healthcare through connected devices and diagnostics, is thrilled to announce its strategic partnership with the Elation Partner Hub. This collaboration aims to integrate Impilo's innovative platform with Elation Health's top-rated Electronic Health Records (EHR) system, focusing on elevating patient care, streamlining workflows, and optimizing health outcomes for patients at home.
Seamless Integration for Superior Patient Care
The integration between Impilo and Elation Health is designed to empower healthcare providers by simplifying the process of procuring and delivering necessary medical devices directly to patients. This synchronized approach allows for efficient management of remote monitoring devices, enabling patients to receive vital support in the comfort of their homes. This partnership reflects Impilo’s ongoing commitment to making healthcare delivery accessible and efficient.
Driving Innovation in Virtual Care
Since its founding in 2020, Impilo has been an essential pillar in the realm of virtual care. It has set up a plug-and-play solution that not only provides remote monitoring devices but also delivers logistics and support services through a robust API infrastructure. By removing barriers to access, Impilo is dedicated to enhancing the way healthcare is delivered, ensuring that both providers and patients benefit from its extensive offerings.
Transforming Healthcare Experiences
Josh Stein, the Founder & CEO of Impilo, shared, "Our mission is to dismantle barriers to care, making healthcare accessible for everyone. Through our partnership with Elation Health, we are equipped to empower healthcare providers with essential tools that allow them to manage remote patient care effectively." This initiative underscores the significance of ensuring patients receive timely and personalized support.
Elation Health’s Commitment to Primary Care
Complementing Impilo’s vision, Elation Health is committed to supporting primary care professionals by mitigating administrative challenges and enhancing relationships with patients. With over 36,000 clinicians entrusting their practices to Elation Health, their technology has successfully facilitated care for more than 16 million patients, validating its effectiveness in various healthcare environments.
Funding to Support Continued Growth
This strategic partnership comes on the heels of Impilo securing $11.5 million in a Series A funding round, spearheaded by Construct Capital. These funds are intended to expand Impilo's reach within the healthcare provider and payer sectors, furthering its mission to support digital health initiatives. With the integration of Elation Health's platform, Impilo is set to significantly enhance its service offerings.
About Impilo
Impilo is dedicated to empowering healthcare organizations to launch and expand their connected care programs in virtual environments. It offers seamless integration of remote monitoring devices and supplies through a versatile platform that features logistics, tech-enabled services, and a strong API framework. Serving a diverse range of healthcare stakeholders—including Accountable Care Organizations (ACOs), medical device manufacturers, community health centers, and digital health firms—Impilo continues to redefine remote care delivery. For more details, visit www.impilo.health.
About Elation Health
Elation Health is recognized as a pivotal technology partner in primary care, with solutions designed to empower clinicians with innovative workflow and AI capabilities tailored for quality care delivery. Their services have supported over 36,000 clinicians handling the health needs of more than 18 million individuals, demonstrating the platform's robust capabilities in medical settings. Learn more about their offerings at elationhealth.com, or through their social media profiles on LinkedIn and X.
Frequently Asked Questions
What is the purpose of the partnership between Impilo and Elation Health?
This partnership aims to integrate Impilo's platform with Elation Health's EHR to enhance patient care and streamline clinical workflows.
How does Impilo improve at-home healthcare delivery?
Impilo provides remote monitoring devices and logistics to ensure patients receive essential medical support from their homes.
Who benefits from the integration of these two platforms?
Healthcare providers and patients alike benefit from improved tools for managing remote care and better access to medical resources.
What recent funding has Impilo secured for its operations?
Impilo recently raised $11.5 million in a Series A funding round led by Construct Capital to expand its services in the healthcare sector.
How does Elation Health support primary care clinicians?
Elation Health assists clinicians by alleviating administrative burdens, allowing them to focus more on patient care and relationships.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
